most-medicare-beneficiaries-may-pay-more-for-drugs-under-the-inflation-reduction-act

Part D schemes are hastening the transfer of expenses to recipients, a significant number of whom will not meet the statute’s updated expenditure limit, according to a white paper from the USC Schaeffer Center.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This